Operating Lease, Right-of-Use Asset of Immunovant, Inc. from 31 Mar 2020 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Immunovant, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2020 to 31 Mar 2025.
  • Immunovant, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Mar 2025 was $98,000, a 26% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Immunovant, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $98,000 -$35,000 -26% 31 Mar 2025 10-K 29 May 2025 2025 FY
Q4 2024 $22,000 -$272,000 -93% 31 Dec 2024 10-Q 06 Feb 2025 2025 Q3
Q3 2024 $45,000 -$544,000 -92% 30 Sep 2024 10-Q 07 Nov 2024 2025 Q2
Q2 2024 $66,000 -$816,000 -93% 30 Jun 2024 10-Q 06 Aug 2024 2025 Q1
Q1 2024 $133,000 -$1,039,000 -89% 31 Mar 2024 10-K 29 May 2025 2025 FY
Q4 2023 $294,000 -$1,165,000 -80% 31 Dec 2023 10-Q 12 Feb 2024 2024 Q3
Q3 2023 $589,000 -$1,154,000 -66% 30 Sep 2023 10-Q 09 Nov 2023 2024 Q2
Q2 2023 $882,000 -$1,142,000 -56% 30 Jun 2023 10-Q 10 Aug 2023 2024 Q1
Q1 2023 $1,172,000 -$1,131,000 -49% 31 Mar 2023 10-K 29 May 2024 2024 FY
Q4 2022 $1,459,000 -$993,000 -40% 31 Dec 2022 10-Q 03 Feb 2023 2023 Q3
Q3 2022 $1,743,000 -$988,000 -36% 30 Sep 2022 10-Q 04 Nov 2022 2023 Q2
Q2 2022 $2,024,000 -$984,000 -33% 30 Jun 2022 10-Q 05 Aug 2022 2023 Q1
Q1 2022 $2,303,000 -$979,000 -30% 31 Mar 2022 10-K 22 May 2023 2023 FY
Q4 2021 $2,452,000 -$1,017,000 -29% 31 Dec 2021 10-Q 04 Feb 2022 2022 Q3
Q3 2021 $2,731,000 -$762,000 -22% 30 Sep 2021 10-Q 05 Nov 2021 2021 Q2
Q2 2021 $3,008,000 -$1,192,000 -28% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q1
Q1 2021 $3,282,000 +$3,282,000 31 Mar 2021 10-K 08 Jun 2022 2022 FY
Q4 2020 $3,469,000 31 Dec 2020 10-Q 16 Feb 2021 2021 Q3
Q3 2020 $3,493,000 30 Sep 2020 10-Q 12 Nov 2020 2021 Q2
Q2 2020 $4,200,000 30 Jun 2020 10-K 01 Jun 2021 2020 FY
Q1 2020 $0 31 Mar 2020 10-K 01 Jun 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.